Biogen: Arthritis, Rheumatoid trials

The registry lists 15 Arthritis, Rheumatoid studies with Biogen as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 10No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid ArthritisTerminatedNCT00298272Phase 2Results posted
• Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving MethotrexateTerminatedNCT00083759Phase 2Results posted
• A Real-world Study of Imraldi® UseCompletedNCT04089514
• One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyCompletedNCT03662919
• Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From EnbrelCompletedNCT03100734
• BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic DrugsWithdrawnNCT01652937Phase 2
• Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive PatientsCompletedNCT01211678
• A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201TerminatedNCT00831649Phase 2
• Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT00810836Phase 2
• BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid ArthritisCompletedNCT00771329Phase 1
• Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) ParticipantsCompletedNCT00664716Phase 2
• 104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) ParticipantsTerminatedNCT00664573Phase 2
• BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)TerminatedNCT00523328Phase 2
• BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid ArthritisTerminatedNCT00458861Phase 2
• Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid ArthritisCompletedNCT00292422Phase 2